Search Results for babylon health

TTA’s Realignment Autumn 7, Turkey Week Edition: Babylon’s decent Q3, more Oracle misery at VA, DOJ appeals UHG-Change, Walmart loses senior exec to JPM, health tech funding yellow flagged to 2025

  Weekly Alert As usual in the rollup to (US) Thanksgiving, it’s a light news week. Our two roundups include Babylon Health’s encouraging Q3 results, DOJ’s appealing to block the UHG-Change buy–already closed (!)–an senior exec move from Walmart Health to JPM, and digital health/health tech funding yellow flagged to 2025 by Very Important Investors. Mid-week news briefs: House members’ ‘grave concerns’ on two deaths tied to Oracle Cerner VA rollout; care.ai’s $27M funding; Clear Arch’s new mobile RPM platform; digital health investment in rough times News roundup: Babylon Health Q3 revenue up 3.9x; surprise–DOJ to appeal UHG-Change buy approval;... Continue Reading

News roundup: Babylon Health Q3 revenue up 3.9x; surprise–DOJ to appeal UHG-Change buy approval; Walmart loses senior health exec Pegus to JPM

...$1.05 billion to $1.1 billion. Babylon is selling Meritage Medical Network, an independent physician association (IPA) based in Northern and Central California with 1,800 providers in six counties serving 90,000 patients, advised by a major investment bank. They will also comply with SEC reporting requirements for a domestic issuer versus previously as a foreign private issue. Babylon will report its Q4 and 2022 yearend results under U.S. GAAP. They are also proceeding with a 25-to-1 reverse stock split to boost share price and prevent a NYSE delisting [TTA 13 Oct]. Mobihealthnews The Department of Justice (DOJ) wiped egg off its... Continue Reading

TTA’s Realignment Autumn 6: Theranos’ Holmes gets 11 years on fraud, Cerebral ex-CEO’s legal fishing, Amazon Clinic and Primasun debut, Maven rounds up $90M, Sema4 ditches women’s health + 500

...buy; Signify adds home RPM; BioIntelliSense RPM acquires AlertWatch; GE Healthcare, AMC Health partner; Viome raises $67M, other fundings Rosendorff stands pat on Theranos’ Elizabeth Holmes: “She needs to pay her debt to society” (He’s right–and now he needs a job and a relo) There’s no escaping realignments in health tech. CVS sells an inherited business from Aetna. Babylon Health exits the practice business, financially maneuvers to avoid NYSE delisting. Layoffs continue to hit the formerly hot companies in health tech. Theranos’ Holmes and Balwani try to avoid the inevitable sentencing. And we have a Perspectives contribution from Avaya on... Continue Reading

TTA’s Realignment Autumn 5: VillageMD-Summit Health deal, Oracle restructures debt, future of health tech funding, new partners/products from Tyto, Get Well, TEC Cymru, Amazon Clinic, more!

...Health; Zuckerberg getting Senate scrutiny (Not going away despite denials and Zuckerbucks) Breaking: CVS’ Signify Health buy under DOJ scrutiny in ‘second request’ (DOJ and FTC crave an antitrust win) News roundup: CVS abandons (?) Cano Health buy; Signify adds home RPM; BioIntelliSense RPM acquires AlertWatch; GE Healthcare, AMC Health partner; Viome raises $67M, other fundings Rosendorff stands pat on Theranos’ Elizabeth Holmes: “She needs to pay her debt to society” (He’s right–and now he needs a job and a relo) There’s no escaping realignments in health tech. CVS sells an inherited business from Aetna. Babylon Health exits the practice... Continue Reading

TTA’s Realignment Autumn 4: VillageMD-Summit?, another Meta Pixel suit, Data Saves Lives, JPM’s health VC forms, partnerships, M&A, more!

...health tech. CVS sells an inherited business from Aetna. Babylon Health exits the practice business, financially maneuvers to avoid NYSE delisting. Layoffs continue to hit the formerly hot companies in health tech. Theranos’ Holmes and Balwani try to avoid the inevitable sentencing. And we have a Perspectives contribution from Avaya on NHS England’s ICS. Theranos’ Holmes sentencing now 18 November, defense wants to expand hearing scope; Balwani can’t join in News roundup: CVS sells bswift; Babylon puts Meritage IPA up for sale, financially realigning to prevent delisting; Redesign Health sheds 20%, Noom 10% Perspectives: How joined-up communications can enable connected... Continue Reading

TTA’s Realignment Autumn 3: wobbly global health funding, telehealth. Oracle funding Cerner buy; Teladoc narrows loss, smartwatches accelerate, Theranos defense reaches ‘mental’ state, more!

...and a relo) There’s no escaping realignments in health tech. CVS sells an inherited business from Aetna. Babylon Health exits the practice business, financially maneuvers to avoid NYSE delisting. Layoffs continue to hit the formerly hot companies in health tech. Theranos’ Holmes and Balwani try to avoid the inevitable sentencing. And we have a Perspectives contribution from Avaya on NHS England’s ICS. Theranos’ Holmes sentencing now 18 November, defense wants to expand hearing scope; Balwani can’t join in News roundup: CVS sells bswift; Babylon puts Meritage IPA up for sale, financially realigning to prevent delisting; Redesign Health sheds 20%, Noom... Continue Reading

TTA’s Realignment Autumn 2: back to 2017 or 2018 with Theranos, Meta Pixel’s breaches, antitrust on CVS-Signify, downscaled deals and partnerships

...in health tech. CVS sells an inherited business from Aetna. Babylon Health exits the practice business, financially maneuvers to avoid NYSE delisting. Layoffs continue to hit the formerly hot companies in health tech. Theranos’ Holmes and Balwani try to avoid the inevitable sentencing. And we have a Perspectives contribution from Avaya on NHS England’s ICS. Theranos’ Holmes sentencing now 18 November, defense wants to expand hearing scope; Balwani can’t join in News roundup: CVS sells bswift; Babylon puts Meritage IPA up for sale, financially realigning to prevent delisting; Redesign Health sheds 20%, Noom 10% Perspectives: How joined-up communications can enable... Continue Reading

News roundup: CVS sells bswift; Babylon puts Meritage IPA up for sale, financially realigning to prevent delisting; Redesign Health sheds 20%, Noom 10%

...These address a major problem that threatened Babylon’s listing on the New York Stock Exchange (NYSE). In September, Babylon received notice that it violated NYSE rules in not maintaining an average closing share price of at least $1 over 30 consecutive days. Today’s close (12 October) was $0.42. A reverse split will boost the stock price and prevent Babylon from being delisted. Babylon release, Mobihealthnews After a brief break, healthcare layoffs continue even at richly valued companies with recent raises. Redesign Health is releasing 20% of its workforce, or 67 people from its NYC-based workforce. This is one month after... Continue Reading

Babylon Health exits last NHS hospital contract as a ‘distraction’, looks to US market for growth

Babylon Health’s rollercoaster ride continues. Today’s news was that their last of three NHS Trust contracts, with Royal Wolverhampton NHS Trust (RWT), was ended by Babylon two years into a ten-year contract. This follows the end of two other contracts that drew a fair amount of controversy (see our index here)–the 2020 one-year Royal Berkshire NHS Foundation Trust with an accident and emergency triage app that was discontinued by Babylon, and with University Hospitals Birmingham NHS Foundation Trust (UHB) for a virtual A&E app that was ended in July. In the UK, Babylon will continue its GP At Hand service... Continue Reading

Babylon Health: fending off bubbly rumors of acquisition this week

On Monday, the New York Stock Exchange stopped trading of Babylon Holdings Limited (NYSE:BBLN), the corporate name of Babylon Health. The reason was a sudden spike in the share price along with a huge spike in trading volume. Price moved from $0.76 to $0.96 from 12.45 pm ET to 1.15pm, with volume spiking from ~3,000 to 1 million (see the bottom bar chart). The volume and price shift automatically trigger a stop trade. Based on the Yahoo Finance chart, it resumed Tuesday morning and cruised down to just above recent prices at $0.77 closing today at $0.79, along with a... Continue Reading